Cancer patients, especially stem cell transplantation recipients and patients with leukemia, constitute a high-risk group for the development of life-threatening systemic fungal infections. Candidiasis represents the most commonly reported fungal infection in cancer patients. Candidemia alone is associated with a mortality rate above 50% in this patient population. Even more challenging than th...

Pulmonary infections caused by Aspergillus species are associated with significant morbidity and mortality in immunocompromised patients. Although the treatment of pulmonary fungal infections requires the use of systemic agents, aerosolized delivery is an attractive option in prevention because the drug can concentrate locally at the site of infection with minimal systemic exposure. Current cli...

The warm tropical climate of the Philippines and its interaction with cultural practices, occupation and immune responsiveness contribute to the increased susceptibility of Filipinos to fungal infections. An investigation to determine the prevalence of fungal infections in dermatology training institutions over a 4-year period was conducted. The results showed that fungal infections rank as the...

A major global concern is the emergence and spread of systemic life-threatening fungal infections in critically ill patients. The increase in invasive fungal infections, caused most commonly by Candida and Aspergillus species, occurs in patients with impaired defenses due to a number of reasons such as underlying disease, the use of chemotherapeutic and immunosuppressive agents, broad-spectrum ...

The frequency of severe systemic fungal diseases has increased in the last few decades. The clinical use of broad spectrum antibacterial drugs and immunosuppressive agents after organ transplantation, cancer chemotherapy, and advancements in surgery are associated with increasing risk of fungal infection. Despite the effectiveness of available antifungals in combating such infections, the emerg...

introduction cryptococcosis is an opportunistic fungal infection mostly in immunocompromised patients. here we present the immunocompetent case with crypotoccosis. case presentation a 60-year-old man without any history of immunodeficiency or major risk factor of fungal infection, referred to the emergency department with systemic symptoms and low back pain. the patient’s condition gradually de...

Fungal infections are emerging as a major problem in part due to high mortality associated with systemic infections, especially in the case of immunocompromised patients. With the development of new treatments for diseases such as cancer and the acquired immune deficiency syndrome pandemic, the number of immunosuppressed patients has increased and, as a consequence, also the number of invasive ...